{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:36:13Z","timestamp":1789994173819,"version":"4.0.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"suppl_6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"DOI":"10.1093\/cid\/civ676","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T06:47:40Z","timestamp":1447397260000},"page":"S601-S603","source":"Crossref","is-referenced-by-count":9,"title":["Development of New Strategies for Echinocandins: Progress in Translational Research"],"prefix":"10.1093","volume":"61","author":[{"given":"Thomas J.","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkechi","family":"Azie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Andes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"key\n\t\t\t\t20171013230115_CIV676C1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171013230115_CIV676C2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/INF.0b013e31821b95e2","article-title":"Echinocandins in children","volume":"30","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171013230115_CIV676C3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/fmb.11.19","article-title":"Current perspectives on echinocandin class drugs","volume":"6","year":"2011","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20171013230115_CIV676C4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1517\/13543784.15.11.1319","article-title":"Developments in the treatment of candidiasis: more choices and new challenges","volume":"15","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"issue":"(suppl 6)","key":"key\n\t\t\t\t20171013230115_CIV676C5","first-page":"S604","article-title":"Echinocandins: the expanding antifungal armamentarium","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"(suppl 6)","key":"key\n\t\t\t\t20171013230115_CIV676C6","first-page":"S612","article-title":"Echinocandin resistance in Candida","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"key\n\t\t\t\t20171013230115_CIV676C7","article-title":"Fungal biofilms, drug resistance, and recurrent infection","volume":"4","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key\n\t\t\t\t20171013230115_CIV676C8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/338714","article-title":"Should vascular catheters be removed from all patients with candidemia? An evidence-based review","volume":"34","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"(suppl 6)","key":"key\n\t\t\t\t20171013230115_CIV676C9","first-page":"S618","article-title":"The role of echinocandins in Candida biofilm\u2013related vascular catheter infections: in vitro and in vivo model systems","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013230115_CIV676C10","article-title":"Systemic and lock therapies with micafungin (MFG) eradicate experimental catheter-based biofilms and infections caused by Candida albicans (CA) and Candida parapsilosis (CP). Late breaker presentation [abstract M-456a]","year":"2014"},{"issue":"(suppl 6)","key":"key\n\t\t\t\t20171013230115_CIV676C11","first-page":"S622","article-title":"Role of echinocandins in fungal biofilm\u2013related disease: vascular catheter\u2013related infections, immunomodulation, and mucosal surfaces","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"(suppl 6)","key":"key\n\t\t\t\t20171013230115_CIV676C12","first-page":"S630","article-title":"Characteristics, clinical relevance, and the role of echinocandins in fungal\u2013bacterial interactions","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"(suppl 6)","key":"key\n\t\t\t\t20171013230115_CIV676C13","first-page":"S635","article-title":"Single or 2-dose micafungin regimen for treatment of invasive candidiasis: therapia sterilisans magna!","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"(suppl 6)","key":"key\n\t\t\t\t20171013230115_CIV676C14","first-page":"S643","article-title":"Intermittent dosing of micafungin is effective for treatment of experimental disseminated candidiasis in persistently neutropenic rabbits","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013230115_CIV676C15","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.3109\/10428194.2014.885514","article-title":"Safety of high-dose micafungin for patients with hematological diseases","volume":"55","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20171013230115_CIV676C16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/clpt.2009.200","article-title":"Safety and pharmacokinetics of repeat-dose micafungin in young infants","volume":"87","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20171013230115_CIV676C17","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1128\/AAC.05193-11","article-title":"Fractal geometry and the pharmacometrics of micafungin in overweight, obese, and extremely obese people","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013230115_CIV676C18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1128\/AAC.49.4.1331-1336.2005","article-title":"Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013230115_CIV676C19","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/AAC.49.8.3317-3324.2005","article-title":"Safety, tolerability, and pharmacokinetics of micafungin (FK463) in febrile neutropenic pediatric patients","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013230115_CIV676C20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/INF.0b013e3181910e2d","article-title":"Pharmacokinetics of an elevated dosage of micafungin in premature neonates","volume":"28","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171013230115_CIV676C21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.bmt.1705398","article-title":"A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation","volume":"38","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"(suppl 6)","key":"key\n\t\t\t\t20171013230115_CIV676C22","first-page":"S652","article-title":"Safety and efficacy of intermittent intravenous administration of high-dose micafungin","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013230115_CIV676C23","article-title":"Cardiac response to centrally administered echinocandin antifungals","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"key\n\t\t\t\t20171013230115_CIV676C24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jcpt.12108","article-title":"Cardiac toxicity of the echinocandins: chance or cause and effect association?","volume":"39","year":"2014","journal-title":"J Clin Pharm Ther"},{"issue":"(suppl 6)","key":"key\n\t\t\t\t20171013230115_CIV676C25","first-page":"S662","article-title":"Antifungal-associated drug\u2013induced cardiac disease","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013230115_CIV676C26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2217\/fmb.12.31","article-title":"The postantifungal and paradoxical effects of echinocandins against Candida spp","volume":"7","year":"2012","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20171013230115_CIV676C27","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1128\/AAC.00291-06","article-title":"Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013230115_CIV676C28","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1128\/AAC.01480-08","article-title":"Anidulafungin is fungicidal and exerts a variety of postantifungal effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013230115_CIV676C29","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1128\/AAC.00563-06","article-title":"Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013230115_CIV676C30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diagmicrobio.2004.10.006","article-title":"Studies of the paradoxical effect of caspofungin at high drug concentrations","volume":"51","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171013230115_CIV676C31","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1128\/AAC.00854-09","article-title":"Transcriptional regulation of chitin synthases by calcineurin controls paradoxical growth of Aspergillus fumigatus in response to caspofungin","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"(suppl 6)","key":"key\n\t\t\t\t20171013230115_CIV676C32","first-page":"S669","article-title":"Potential microbiological effects of higher dosing of echinocandins","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"(suppl 6)","key":"key\n\t\t\t\t20171013230115_CIV676C33","first-page":"S678","article-title":"The regulatory pathway for antifungal drugs: a US perspective","volume":"61","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/suppl_6\/S601\/20913635\/civ676.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T23:01:21Z","timestamp":1507935681000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/61\/suppl_6\/S601\/436321\/Development-of-New-Strategies-for-Echinocandins"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":33,"journal-issue":{"issue":"suppl_6","published-online":{"date-parts":[[2015,11,5]]},"published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ676","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,12,1]]},"published":{"date-parts":[[2015,11,5]]}}}